Development of an experimental model of induced bacterial peritonitis in cirrhotic rats with or without ascites

American Journal of Gastroenterology

Volumn 102, Issue 6, 2007, Pages 1230-1236

  Sánchez, Elisabet ^a,d   Such, José ^b,d   Teresa Chiva, Maite ^a   Soriano, Germán ^a,d   Llovet, Teresa ^a   Mercè, Javier ^a   Sancho, Francisco ^a   Muñoz, Carlos ^b,d   Song, Xiao Yu ^c   Pérez Mateo, Miguel ^b,d   Balanzó, Joaquín ^a,d   Guarner, Carlos ^a,d,e  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^c CENTOCOR INC   (United States)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

^e UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON TETRACHLORIDE; CEFTRIAXONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; ASCITES; BACTERIAL PERITONITIS; BACTERIUM COLONY; COLONY FORMING UNIT; CONTROLLED STUDY; ESCHERICHIA COLI; LIVER CIRRHOSIS; MORTALITY; NONHUMAN; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; RANDOMIZATION; RAT;

ANIMALS; ANTI-BACTERIAL AGENTS; ASCITES; BACTERIAL INFECTIONS; CARBON TETRACHLORIDE; CEFTRIAXONE; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI INFECTIONS; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; PERITONITIS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 34249105815     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01182.x     Document Type: Article

References (30)

1. Llovet JM, Planas R, Morillas R, et al. Short-term prognosis of cirrhotics with spontaneous bacterial peritonitis: Multivariate study. Am J Gastroenterol 1993;88:388-92.
2. Toledo C, Salmeron JM, Rimola A, et al. Spontaneous bacterial peritonitis in cirrhosis: Predictive factors of infection resolution and survival in patients treated with cefotaxime. Hepatology 1993;17:251-7.
3. Guarner C, Runyon BA. Spontaneous bacterial peritonitis: Pathogenesis, diagnosis, and management. Gastroenterologist 1995;3:311-28.
4. Rimola A, Garcia-Tsao G, Navasa M, et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: A consensus document. International Ascites Club. J Hepatol 2000;32:142-53.
5. Navasa M, Casafont F, Clemente G, et al. Consensus on spontaneous bacterial peritonitis in liver cirrhosis: Diagnosis, treatment, and prophylaxis. Gastroenterol Hepatol 2001;24:37-46.
6. Felisart J, Rimola A, Arroyo V, et al. Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections. Hepatology 1985;5:457-62.
7. Follo A, Llovet JM, Navasa M, et al. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: Incidence, clinical course, predictive factors and prognosis. Hepatology 1994;20:1495-501.
8. Sort P, Navasa M, Arroyo V, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.N Engl J Med 1999;341:403-9.
9. López-Novoa JM, Rengel M, Hernando L. Dynamics of ascites formation in rats with experimental cirrhosis. Am J Physiol 1980;238:F353-7.
10. Jiménez W, Clària J, Arroyo V, et al. Carbon tetrachloride induced cirrhosis in rats: A useful tool for investigating the pathogenesis of ascites in chronic liver disease. J Gastroenterol Hepatol 1992;7:90-7.
11. Llovet JM, Bartoli R, Planas R, et al. Bacterial translocation in cirrhotic rats. Its role in the development of spontaneous bacterial peritonitis. Gut 1994;35:1648-52.
12. Garcia-Tsao G, Lee F-Y, Barden GE, et al. Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites. Gastroenterology 1995;108:1835-41.
13. Guarner C, Runyon BA, Young S, et al. Intestinal bacterial overgrowth and bacterial translocation in an experimental model of cirrhosis in rats. J Hepatol 1997;26:1372-8.
14. Bosch-Marcé M, Jiménez W, Angeli P, et al. Aquaretic effect of the k-opioid agonist RU 51599 in cirrhotic rats with ascites and water retention. Gastroenterology 1995;109:217-23.
15. Castro A, Jiménez W, Clarià J, et al. Impaired responsiveness to angiotensin in experimental cirrhosis: Role of nitric oxide. Hepatology 1993;18:367-72.
16. Bosch J. Effect of pharmacological agents on portal hypertension: A haemodynamic appraisal. Clin Gastroenterol 1985;14:169-84.
17. Llovet JM, Bartolí R, Planas R. Bacterial infection of the ascitic fluid in rats with carbon-tetrachloride-induced cirrhosis. In:Arroyo V, Ginés P, Rodés J, et al., eds. Ascites and renal dysfunction in liver disease. Pathogenesis, diagnosis and treatment. Malden, MA: Blackwell Science, 1999:397-408.
18. Dunn DL, Barke RA, Ahrenholz DH, et al. The adjuvant effect of peritoneal fluid in experimental peritonitis. Ann Surg 1984;199:37-43.
19. Runyon BA, Sugano S, Kanel G, et al. A rodent model of cirrhosis, ascites and bacterial peritonitis. Gastroenterology 1991;100:489-93.
20. Runyon BA, Squier S, Borzio M. Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis. J Hepatol 1994;21:792-6.
21. Guarner C, Soriano G. Spontaneous bacterial peritonitis. Semin Liver Dis 1997;17:203-17.
22. Fromkes JJ, Thomas FB, Mekhjian HS, et al. Antimicrobial activity of human ascitic fluid. Gastroenterology 1977;73:668-72.
23. Runyon BA. Patients with deficient ascitic fluid opsonic activity are predisposed to spontaneous bacterial peritonitis. Hepatology 1988;8:632-5.
24. Runyon BA. Low-protein-concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis. Gastroenterology 1986;91:1343-6.
25. Such J, Guarner C, Enríquez J, et al. Low C3 in cirrhotic ascites predisposes to spontaneous bacterial peritonitis. J Hepatol 1988;6:80-4.
26. Such J, Guarner C, Chiva MT, et al. A polymerase chain reaction-based method detects a high incidence of bacterial translocation in cirrhotic rats with negative conventional cultures. Hepatology 2002;36:524A.
27. Francés R, Munoz C, Zapater P, et al. Bacterial DNA activates cell mediated immune response and nitric oxide overproduction in peritoneal macrophages from patients with cirrhosis and ascites. Gut 2004;53:860-4.
28. Utaisincharoen P, Kespichayawattana W, Anuntagool N, et al. CpG ODN enhances uptake of bacteria by mouse macrophages. Clin Exp Immunol 2003;132:70-5.
29. Claria J, Jimenez W, Arroyo V, et al. Blockade of the hydroosmotic effect of vasopressin normalizeswater excretion in cirrhotic rats. Gastroenterology 1989;97:1294-9.
30. Dunn DL, Barke RA, Knight NB, et al. Role of resident macrophages, peritoneal neutrophils, and translymphatic absorption in bacterial clearance from the peritoneal cavity. Infect Immun 1985;49:257-64.